Owlet Baby Care

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Owlet Baby Care sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 2 currently recruiting 7 completed top decile by trial count

Owlet Baby Care: 9 sponsored US clinical trials, 2 recruiting.

Owlet Baby Care sponsors 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Hypoxia, with 3 trials.

Top-decile sponsor footprint

Owlet Baby Care ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Owlet Baby Care pipeline

2 recruiting of 9 indexed (22% open); 7 completed (78%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hypoxia (3 trials), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Owlet Baby Care: open-pipeline peers nationwide

Peers matched on 9 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Owlet Baby Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 8101214161820 0%10%20%30%40%50% Total trials Recruiting share Owlet Baby Care4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyALX OncologyBiosense WebsterEnglewood Hospital and Medical CenterEnsysce Biosciences
Owlet Baby Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Owlet Baby Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

What to do with this Owlet Baby Care page

9 registered trials is a research-attention snapshot, not an endorsement of Owlet Baby Care or any single study.

  • 2 of Owlet Baby Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypoxia is the condition Owlet Baby Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoxia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Owlet Baby Care pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.